SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 43 filers reported holding SIO GENE THERAPIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $106 | – | 244 | +114.0% | 0.00% | – |
| Q3 2022 | $0 | – | 114 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 114 | -98.7% | 0.00% | – |
| Q1 2022 | $6,000 | -77.8% | 8,466 | -60.4% | 0.00% | – |
| Q4 2021 | $27,000 | -41.3% | 21,377 | +0.6% | 0.00% | – |
| Q3 2021 | $46,000 | – | 21,258 | +106190.0% | 0.00% | – |
| Q2 2021 | $0 | – | 20 | -28.6% | 0.00% | – |
| Q1 2021 | $0 | – | 28 | +1300.0% | 0.00% | – |
| Q4 2020 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,969,987 | $8,108,000 | 0.98% |
| Opaleye Management Inc. | 2,000,000 | $5,258,000 | 0.87% |
| Rubric Capital Management LP | 3,000,000 | $8,190,000 | 0.52% |
| Prosight Management, LP | 256,115 | $699,000 | 0.44% |
| ACT CAPITAL MANAGEMENT, LLC | 185,000 | $506,000 | 0.26% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,489,000 | $14,985,000 | 0.22% |
| GSA CAPITAL PARTNERS LLP | 363,887 | $993,000 | 0.11% |
| KNOTT DAVID M | 80,000 | $218,000 | 0.08% |
| Hudson Bay Capital Management LP | 1,540,000 | $4,204,000 | 0.05% |
| APOGEM CAPITAL LLC | 19,401 | $53,000 | 0.03% |